ASAleksandr B. Sagakyants

Aleksandr B. Sagakyants

*This is an algorithmically generated author record based on publicly available information.

Aleksandr B. Sagakyants has a total of 300 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ВЗАИМОСВЯЗЬ ВЫЖИВАЕМОСТИ ПАЦИЕНТОВ С КЛИНИЧЕСКИМИ ХАРАКТЕРИСТИКАМИ И ОСОБЕННОСТЯМИ ЭКСПРЕССИИ CD68/CD206 ПРИ ПЛОСКОКЛЕТОЧНОМ РАКЕ ЛЁГКОГО IIIA СТАДИИ.

    by А.а. Антонян, Е.п. Ульянова, Д.а. Харагезов, Е.ю. Златник, А.б. Сагакянц, В.н. Витковская, Е.а. Дженкова, Ю.с. Шатова, А.н. Шевченко

    Опухоль-ассоциированные макрофаги являются важным компонентом микроокружения немелкоклеточного рака лёгкого; их плотность и пространственное распределение могут быть связаны с клиническим течением заболевания. Целью исследования была оценка связи общей выживаемости пациентов с плоскоклеточным раком лёгкого IIIA стадии с клиническими характеристиками и особенностями экспрессии маркеров CD68 и CD206 в строме и паренхиме опухоли. Исследование выполнено на материале 31 пациента с плоскоклеточным раком лёгкого IIIA стадии, которым первым этапом было проведено хирургическое лечение в 2018–2020 годах в Федеральном государственном бюджетном учреждении «Национальный медицинский исследовательский центр онкологии» Министерства здравоохранения Российской Федерации. Для прогностической оценки пациенты были разделены по медиане общей выживаемости, составившей 42 месяца, на группы короткой и длительной выживаемости. Иммуногистохимическое исследование выполняли с использованием антител к CD68 и CD206. Для статистической обработки применяли критерий Манна – Уитни, критерий хи-квадрат Пирсона, точный критерий Фишера и коэффициент корреляции Спирмена. Более высокая экспрессия CD68 в строме была связана с лучшей общей выживаемостью. Для CD68 в паренхиме и CD206 в исследуемых зонах статистически значимых различий между группами выживаемости не выявлено. Среди клинических факторов неблагоприятный прогноз был связан с выполнением пневмонэктомии и наличием коморбидности. В группе длительной выживаемости выявлена значимая отрицательная корреляция между экспрессией CD68 в строме и CD206 в паренхиме, тогда как у пациентов с короткой выживаемостью сопоставимой структуры взаимосвязей не наблюдалось. Прогностическая значимость опухоль-ассоциированных макрофагов при плоскоклеточном раке лёгкого IIIA стадии определяется не только их плотностью, но и пространственной организацией между стромой и паренхимой опухоли. Экспрессия CD68 в строме может рассматриваться как потенциальный прогностический маркер, а совместная оценка CD68 в строме и CD206 в паренхиме может повысить точность стратификации риска неблагоприятного течения заболевания.

  • Open Access

    ВЛИЯНИЕ БЕРБЕРИНА НА ФУНКЦИОНАЛЬНЫЕ СВОЙСТВА МОНОНУКЛЕАРНЫХ КЛЕТОК ПЕРИФЕРИЧЕСКОЙ КРОВИ У ПАЦИЕНТОВ С ДИФФУЗНОЙ В-КЛЕТОЧНОЙ КРУПНОКЛЕТОЧНОЙ ЛИМФОМОЙ С РАЗЛИЧНЫМ ОТВЕТОМ НА ТЕРАПИЮ

    by М.с. Казанчян, А.б. Сагакянц, И.б. Лысенко, С.ю. Филиппова, Е.с. Бондаренко, И.в. Межевова, Е.ю. Златник, Я.с. Гайсултанова

    Изучение функционального состояния иммунокомпетентных клеток представляет интерес для поиска дополнительных предикторов ответа на лечение. Цель исследования – провести сравнительную оценку исходного иммунного статуса и функциональной активности мононуклеарных клеток периферической крови при воздействии берберина in vitro у пациентов с противоположным клиническим ответом на терапию (полный метаболический ответ и раннее прогрессирование с летальным исходом). В исследование включены два клинических случая впервые диагностированной лимфомы II стадии с сопоставимыми прогностическими характеристиками и различным исходом лечения. Иммунофенотипирование лейкоцитов периферической крови проводили методом проточной цитометрии с оценкой результатов на BD FACSCanto. Функциональную активность мононуклеарных клеток периферической крови оценивали in vitro методом колониеобразования при воздействии берберина в концентрациях 1, 2 и 4 мкМ в условиях базальной и митогенной (фитогемагглютинин 4 мкг/мл) стимуляции. Количественный анализ колоний выполняли с использованием автоматического клеточного анализатора Lionheart FX. Выявлены различия в субпопуляционном составе лимфоцитов и пролиферативном ответе клеток. Берберин оказывал дозозависимое стимулирующее влияние на колониеобразование, при этом пик ответа различался в зависимости от клинического исхода. Полученные данные свидетельствуют о возможной связи функционального состояния мононуклеарных клеток и их чувствительности к берберину с клиническим ответом при диффузной В-клеточной крупноклеточной лимфоме. Выявленные тенденции обосновывают целесообразность дальнейших исследований берберина как потенциального иммуномодулирующего агента.

  • Gender specificity of angiogenesis in patients with non-muscle invasive bladder cancer complicated by type 2 diabetes mellitus

    by E.M. Ataeva, E.P. Ulyanova, A.B. Sagakyants, I.V. Kaplieva, O.G. Shulgina, E.N. Chernikova, D.A. Shvyrev, V.K. Khvan, A.V. Faenson

    Cancers and diabetes mellitus are among the most common human pathologies, with an increase in morbidity every year. To this date, a relationship of type 2 diabetes mellitus (DM2) with increased risk of development and progression of cancer of many localizations has been established, nevertheless the data on the impact of DM2 on the course of bladder cancer are contradictory. Objective. To study the features of expression of angiogenic proteins — vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule (CD31), to evaluate their gender specificity in non-muscle-invasive bladder cancer, developing in addition to type 2 diabetes mellitus 2, compared with these indicators in bladder cancer emerging without comorbid pathology. Materials and methods. The study was conducted on material of 40 patients of both sexes with a verified urothelial non-muscle-invasive bladder cancer who were treated at «NMRC for Oncology» (Rostov-on-Don) from 2017 to 2022. Monoclonal mouse antibodies to VEGF and CD31 were used for immunohistochemical analysis. Percentage of tumor cells expressing VEGF and number of vessels stained with CD31 marker were determined. Results. A statistically significant exceedance of VEGF expression level by 2.8 times has been noted in patients of the group with DM2 compared to women in the same group (p=0.002) and men without comorbid pathology (p=0.001). The number of CD31-stained vessels was 1.3 times (p=0.042) higher in women of the same group than in men, and 3 times (p=0.009) higher in women without comorbid pathology. Conclusion. The revealed gender specificity of expression of angiogenesis markers in non-muscle-invasive bladder cancer, developing in addition to type 2 diabetes mellitus, can be considered for the prediction of risk of development and progression of this pathology.

  • Open Access

    LOCAL IMMUNE STATUS IN DIFFERENT CLINICAL COURSE OF ENDOMETRIAL CANCER

    by V.V. Polovodova, A.B. Sagakyants, E.S. Bondarenko, E.V. Verenikina, O.G. Shulgina, K.M. Zakaryan, N.A. Maksimova, A.A. Cherkasova, V.M. Zhenilo

  • Open Access

    The role of tumor stem cells and the immune microenvironment in the pathogenesis of lung cancer: mechanisms of interaction and research prospects

    by D. A. Kharagezov, A. A. Antonyan, E. Yu. Zlatni, A. B. Sagakyants, E. A. Mirzoyan, T. G. Ayrapetova, I. A. Leyman, A. G. Milakin, O. N. Stateshny, K. D. Iozefi, et al.

    Despite significant advances in the treatment of malignant neoplasms, the issue of therapy resistance mediated by cancer stem cells (CSCs) necessitates the development of new treatment strategies. Studying the role of CSCs and the immune microenvironment in the pathogenesis of cancer, particularly non-small cell lung cancer (NSCLC), is a pressing issue in modern oncology. This paper is based on an extensive analysis of recent research and aims to study the mechanisms underlying the development of NSCLC.The origin of CSCs, their markers, and the main signaling pathways involved in regulating their activity are considered. Special attention is paid to the influence of CSCs on the progression of lung cancer and the mechanisms underlying their therapy-mediated resistance. Various approaches to treating lung cancer targeting CSCs, focusing on targeted therapy aimed at specific molecular targets, are highlighted.The important role of the tumor immune microenvironment in the pathogenesis of lung cancer and its impact on CSCs is emphasized. Mechanisms of immune response regulation in tumors and the potential use of immunotherapy to improve lung cancer treatment outcomes are discussed. The article also reviews modern diagnostic and treatment methods, including molecular-genetic and immunohistochemical approaches.This paper work represents a review of current knowledge on the mechanisms of lung cancer development and is significant for understanding tumor biology and developing new treatment methods. The need for an interdisciplinary approach and comprehensive use of modern diagnostic and therapeutic methods to improve the prognosis and survival rates of NSCLC patients is emphasized. Special attention is given to the prospects of using combined therapeutic approaches, including targeted drugs and immunotherapy, aimed at suppressing CSC activity and modifying the tumor microenvironment.In conclusion, a deep understanding of the molecular mechanisms regulating CSC activity and their interaction with the tumor microenvironment opens new opportunities for developing effective treatment strategies. This review underscores the need for further research in this area to ensure more successful treatment and improved quality of life for lung cancer patients.


  • Open Access

    Possibilities of using secondary plant metabolites as antitumor agents

    by Elena Yu. Zlatnik, Alexander B. Sagakyants, Eugenia M. Nepomnyashchaya, Natalya A. Zakharova, Yulia V. Ulyanova, Сагакянц Александр Борисович, Непомнящая Евгения Марковна, Захарова Наталья Александровна, Ульянова Юлия Викторовна

    The review summarized the literature data of recent years on the antitumor effect of secondary plant metabolites, as well as their immunotropic and anti-inflammatory effects as components of the antitumor response. The biological basis for the action of secondary plant metabolites was characterized in the form of influence on potential targets: transcription factors, signaling pathways and receptors responsible for proliferation and apoptosis. The ways of increasing the bioavailability of secondary plant metabolites to enhance the effectiveness and possibility of their medicinal use were considered, the effects of berberine, curcumin and their derivatives were described. The search for scientific publications was conducted in foreign (PubMed) and domestic (eLibrary) electronic libraries. It was found that the multiplicity of molecular targets of secondary plant metabolites and the pleiotropy of their effects suggest the possibility of their use for the regulation of various processes in tumor and normal cells. There was a connection between the antitumor effect of secondary plant metabolites and their anti-inflammatory and immunomodulatory action. However, a significant limitation of their use was the fact that most studies were conducted on cell cultures, which was insufficient to judge the antitumor effect. Clinical trials were few and their results were contradictory. In addition, a certain contradiction has been noted between the idea of a more effective action when using a pure substance or a complex composition of various plant components. An important problem was the low bioavailability of most secondary plant metabolites, for which various methods have been proposed. Despite the long history of phytotherapy in oncology, the development of new derivatives of secondary plant metabolites with high water solubility remains relevant, including modified molecules of known secondary plant metabolites and the search for new ones with unexplored biological activity. Modern methods of chemical synthesis and delivery systems of derivatives of secondary plant metabolites, as well as the study of their effects in model experiments, seem to be promising scientific directions for the creation of new drugs with antitumor activity.


  • Open Access

    Bone Marrow Lymphocyte Subpopulation in Chronic Lymphocytic Leukemia Patients with Different Responses to Chemotherapy

    by Olesya Nikolaevna Selyutina, E. Yu. Zlatnik, Н. К. Гуськова, I. A. Novikova, I. B. Lysenko, A. B. Sagakyants, T. F. Pushkareva, L. Yu. Vladimirova

    AIM. To analyze the bone marrow lymphocyte subpopulation based on targeted assessment of PD-1, PD-L1, and LAG-3 marker expression in chronic lymphocytic leukemia (CLL) patients with different responses to chemotherapy. MATERIALS & METHODS. In 33 CLL patients, PD-1, PD-L1, and LAG-3 antigen expression on В-, Т-, and NK-cells of the bone marrow (BM) was analyzed by flow cytofluorometry prior to treatment and after 6 cycles of chemotherapy with rituximab. Patients were aged 58–68 years (median 64 years); there were 14 women and 19 men. Hematologic response was assessed by measurements of minimal residual disease (MRD). On this basis, patients were divided into two groups: group 1 (n = 20) with satisfactory hematologic response (MRD < 1 %) and group 2 (n = 13) with unsatisfactory hematologic response (MRD ≥ 1 %). RESULTS. Prior to treatment, the count of PD-1-, LAG-3-, CD38-, and ZAP-70-expressing BM tumor B-cells was lower in patients of group 1 than in those of group 2. After treatment, their decrease was more pronounced in group 1. Prior to treatment, patients in group 1 had a higher count of BM T-lymphocytes with CD3+, CD4+, CD8+, CD8+/CD28+, CD8+/CD28–, and CD8+/CD38+ phenotype including PD-1- but neither PD-L1- nor LAG-3-expressing T-cells. After treatment, increased T-cells with CD3+, CD4+, CD8+, Treg, CD8+/CD28+, and CD8+/CD28– phenotype including PD-1+ T-lymphocytes were detected in both groups but more pronounced in group 2. In this group, CD3+ и CD4+ T-lymphocytes maintained LAG-3 expression. Prior to treatment, all patients showed decreased NK-cells in BM. After treatment, group 1 showed a higher count of NK-cells with CD3–/CD16+/CD56+ and CD3–/CD16+/CD56+/PD-1+ phenotype and a lower count of NK-cells with CD3–/CD16+/CD56+/LAG-3+ phenotype. PD-L1 expression in NK-cells was not detected, whereas in Т- and В-cells it was moderate prior to treatment and was not identified after hematologic response was achieved. CONCLUSION. The values determined by the targeted assessment of PD-1 and LAG-3 expression in BM В-, Т-, and NK-cells prior to chemotherapy may well be used in clinical practice as additional prognostic factors in CLL. PD-1 and LAG-3 overexpression in Т-lymphocytes and NK-cells in CLL patients with MRD-positive status after chemotherapy can be regarded as evidence of the functional deficiency of these cells.

  • Open Access

    Cellular, genomic and transcriptomic effects of secondary metabolites of the Hybrid Butterbur on the HeLa cell line

    by E. Yu. Zlatnik, Ya. S. Enin, O. N. Burov, E. S. Bondarenko, A. B. Sagakyants, D. S. Kutilin, Yu. V. Dzigunova, I. A. Novikova, Yu. V. Przhedetskiy, Ю. В. Пржедецкий

    Purpose of the study.To evaluate the cellular, genomic (gene copy number) and transcriptomic (gene expression) effects ofP.hybridus(L.) secondary metabolites when they affect the HeLa cell line.Materials and methods.The isolation of secondary metabolites from plant material and its identification were carried out by preparative chromatography. The composition was determined using mass spectrometric analysis, and the final verification of structural formulas was carried out by nuclear magnetic resonance at the Department of Natural Compounds, the Faculty of Chemistry of the Southern Federal University. The subsequent phase of the study was conducted using both cultural and molecular methods. HeLa cells were cultivated under standard conditions in a MEM medium. Once the confluence level was reached 75–80 %, the nutrient medium was replaced with the introduction of the studied compounds (at a concentration of 4 micrograms/ml) and cultivated for 72 hours. Cell mortality was determined using a NanoEnTek JuliFl counter (Korea) in the presence of 0.4 % trypan blue. The assessment of apoptosis following secondary metabolite exposure was conducted on a BD FACSCanto II flow cytometer using the FITC Annexin V Apoptosis Detection Kit I. The level of replication and expression of the genes responsible for apoptosis was assessed by digital droplet PCR (ddPCR).Results.The following compounds were isolated and verified, and were assigned the following sequence numbers to facilitate their use in the experiment: No. 2 – 2,4-dihydroxy-2,5-dimethylfuran-3(2H)-one, No. 3 – 5-(hydroxymethyl) furan-2-carbaldehyde, No. 5.3 – 2,2,8-trimethyldecahydroazulene-5,6-dicarbaldehyde,P. hybridus(L.) At the stage of cell death assessment, it was found that the greatest effect was achieved in the compound under ordinal No. 2. However, the evaluation of the copy number and expression of theCASP8,CASP9,CASP3, BAX, BCL2, TP53, MDM2, CDKN1B, CDK1, CCND1, CCND3, andRB1genes by DD-PCR revealed the presence of apoptosis initiation in tumor cells at the molecular level under the action of compounds No. 2 and No. 5.3 obtained fromP. hybridus(L.).Conclusion.The outcomes were multifeatured. Only compound 2,4-dihydroxy-2,5-dimethylfuran-3(2H)-one exhibited a pronounced cytostatic effect out of all compounds utilized in the experiment. Concurrently, the compound 2,2,8-trimethyldecahydroazulene-5,6-dicarbaldehyde was found to induce an increase in the expression of theCASP3, CASP8, TP53, andBAXgenes.

  • Open Access

    Immunohistochemical parameters of serous ovarian carcinomas and possible mechanism of development of resistance to platinum-based drugs

    by G. V. Zhukova, E. P. Ulyanova, A. P. Menshenina, T. I. Moiseenko, E. Yu. Zlatnik, E. M. Nepomnyashchaya, A. B. Sagakyants, E. V. Verenikina

    The aim of the study was to evaluate a prognostic significance of immunohistochemical parameters in serous ovarian carcinomas and their statistical relationships after neoadjuvant treatment to assess the development of tumor resistance to platinum-containing adjuvant polychemotherapy regimens. Material and Methods. An immunohistochemical study of tumor tissue was carried out in patients with high-grade serous ovarian cancer (stage IIIC–IV). The age of the patients ranged from 49–72 years. There were 59 patients who were sensitive and 22 patients who were resistant to platinum-containing adjuvant polychemotherapy. In the tissue of ovarian tumors obtained during surgery after noadjuvant polychemotherapy, we studied immunohistochemical indicators of proliferative activity (Ki67), expression of the DNA excision repair protein ERCC1 and proteins of the ABC transporter family – Pgp and BCRP, as well as statistical relationships between these indicators (Spearman’s rank correlation coefficient). Results. After effective neoadjuvant polychemotherapy, more pronounced signs of activity in the processes of proliferation, DNA repair and xenobiotic efflux were noted in serous ovarian carcinomas, which subsequently demonstrated resistance to platinum-containing polychemotherapy regimens compared to tumors that retained platinum sensitivity. Moreover, in 40 % of cases or more, there was a coincidence in the ranges of values of the studied parameters in tumors with different sensitivity to platinum drugs. The expression of transporter proteins greater than 60 % for BCRP and 65 % for Pgp was shown to precede the development of resistance to adjuvant treatment with carboplatin. In the studied groups, differences in the number and significance of statistical relationships between the variables were observed. The most significant differences were noted for the Ki67 – BCRP correlation, which had the opposite direction in groups with different sensitivity to adjuvant treatment with carboplatin. Conclusion. A comprehensive immunohistochemical analysis of highgrade serous ovarian carcinomas after neoadjuvant polychemotherapy, which further demonstrated different sensitivity to platinum-containing adjuvant regimens, was carried out, and the prognostic value of the studied parameters was assessed. The revealed critical levels of Pgp and BCRP expression in tumor tissue may have a prognostic value regarding the effect of adjuvant polychemotherapy. The results of the correlation analysis suggest a relationship between the development of platinum resistance and changes in the nature of the regulatory relationships between proliferative activity and transport processes in tumor tissue.


  • Open Access

    Dynamics of saliva cytokine levels during intraoperative photodynamic therapy in patients with locally advanced oral cancer

    by E. Yu. Komarova, E. Yu. Zlatnik, I. A. Novikova, E. A. Dzhenkova, M. A. Engibaryan, A. B. Sagakyants, V. V. Pozdnyakova, L. Ya. Rozenko

    Purpose of the study. Assessment of the level of certain cytokines in the saliva of patients with primary locally advanced cancer of the oral mucosa in addition to surgical treatment with intraoperative PDT (IPDT).Patients and methods. Patients with primary locally advanced cancer of the oral mucosa T3-4aN0-2M0 were divided into 2 groups: the main group (30 patients) underwent radical tumor removal supplemented with IPDT and the control group (30 patients) without addition. IPDT was performed using Latus-T (farah) and a chlorin E6 photosensitizer. Cytokine levels were determined in unstimulated whole saliva the day before, on the 3rd and on the 7th day after the operation by the ELISA multiplex analysis method.Results. A similar dynamic of the cytokine profile of patients of both groups was shown: on the 3rd day after surgery, the levels of G-CSF, IL-6, MIP-1β increased, and GM-CSF and IFN-γ decreased compared with baseline values. On the 7th day, the dynamics of G-CSF, GM-CSF, IL-6 persisted, while IL-8, IL-10, IL-12 changed to the opposite.Intergroup differences were revealed in the level of IL-1β - on day 3, an increase in the main group and a decrease in the control group. The level of IL-7 on day 7 decreased sharply in the control group and increased statistically significantly in patients receiving IPDT. The main group showed a 4.8-fold increase in IL-8 on day 3 and its 3.6-fold drop on day 7 with the opposite dynamics in the control group. The TNF-α level increased only in the main group on day 7, and in the control group it decreased by 3 and recovered on day 7. On day 3, the MCP-1 level increased in the main group and decreased in the control group. The level of IL-17 in the main group increased on the 3rd day with a further decrease below the baseline, and in the control group it decreased on the 3rd day, followed by a recovery on the 7th. An increase in IL-5 and IL-13 levels on day 3 was noted only in the control group, however, the level of IL-5 in both study periods in the main group was lower than in the control group.Conclusion. IPDT in patients with primary locally advanced oral cancer causes changes in the cytokine composition of saliva during the first week after surgery, some of which can be associated with an elongation of the relapse-free period in such patients.